Delivery Order SPE2DR25D6028-SPE2DR26FAQXC
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $56,565.79 for Ciproflo-Dexa 7.5ML on September 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing with an ultimate completion date of October 21, 2025. The award falls under the Medical Supply Chain, a defense-focused federal procurement initiative, with performance to be executed at the company's Conshohocken...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cipro 500 mg tablets (100-count units) at a ceiling value of $1,185.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 14, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under...
- On August 7, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $36,332.90 to AmerisourceBergen Drug Corp for the supply of Ciproflo-Dexa 7.5ml ophthalmic solution. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, with performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a specific fulfillment order under the company's broader...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,375.68 to AmerisourceBergen Drug Corp for the supply of CIPROFLO-DEXA 7.5ML on June 18, 2025, with completion targeted for July 17, 2025. This competitive award, which included no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,624.01 to AmerisourceBergen Drug Corp for the supply of Cipro 5% Suspension in 100ml quantities. The contract, executed on September 24, 2025, with an ultimate completion date of September 25, 2025, carries firm fixed pricing and represents a competitively awarded non-set-aside transaction. Performance will take place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Department's Medical Supply Chain awarded a $1,205.36 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ciprofloxacin 400 mg/200ml diluted in 5% dextrose in water (D5W), with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under a larger contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $40,792.83 delivery order from the Defense Logistics Agency Medical Supply Chain on August 22, 2025, for CIPROFLO-DEXA 7.5ML (Ciprofloxacin-Dexamethasone ophthalmic suspension). This firm fixed-price contract, with a completion date of September 19, 2025, was competitively awarded with no set-aside designation. The delivery order is performance-based in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,549.87 to AmerisourceBergen Drug Corp for 100 tablets of Cipro 500 mg, with an ultimate completion date of July 7, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,388.23 for Cipro 5% Suspension in 100ml quantities, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under a larger indefinite delivery vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,103.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FAQXCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,215.36 to AmerisourceBergen Drug Corp for the supply of Ciproflo-Dexa 7.5ML on October 24, 2025. This competitively awarded, firm fixed-price contract has an ultimate completion date of November 21, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle supporting military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated extensive capability in fulfilling the Defense Logistics Agency's medical supply needs through this and numerous competitively awarded contracts spanning a broad spectrum of pharmaceutical products and medical supplies. The company's federal contract portfolio encompasses brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains, supporting the Defense Health Agency and other government healthcare systems. As the child delivery order under the larger SPE2DX prime IDV, this contract reflects the company's role as a key provider within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 10/24/25 |